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To the Editor: The development of new molecular techniques
in recent years has resulted in the discovery of a number of
novel viruses. Hepatitis C virus (HCV) was the first to be
discovered in 1989 using immunoscreening methods 1 and since
1995 a further five new viruses have been identified using the
same or modified technologies: GB virus-C/hepatitis G virus
(GBV-C/HGV),2,3 human herpesvirus 8 (HHV8),4 TT virus
(TTV),5 SEN virus (SEN-V)6 and human metapneumovirus.7 In
each case the prevalence of the virus in different communities,
its association with disease and therefore its relevance in the
hospital and blood transfusion settings needed to be
established.
These new techniques have the potential to find viruses that
have no association with disease. The determination of a
disease association or lack thereof has major implications for
the health care sector, and particularly the blood transfusion
services. For example, confirmation that the majority of non-A
non-B post-transfusion hepatitis cases were associated with
HCV infection has resulted in screening of blood donors and a
subsequent dramatic drop in the number of transfusion-
association hepatitis cases.8 On the other hand, GBV-C/HGV
was initially thought to play a role in liver disease but this has
been disproved and to date the virus has not been consistently
associated with any other disease. 9 Thus no new diagnostic
interventions were required in hospitals or in the blood
transfusion services.
The following are other examples of recently discovered
viruses. HHV8 has been causally associated with Kaposi’s
sarcoma and other neoplasms in immunodeficient patients and
although transmission via organ transplantation has been
demonstrated, it is not transmitted by blood transfusion.10
Recent studies6 have suggested that certain genotypes of SEN
virus may play a role in non A-E hepatitis, but this has not
been confirmed. Clarification of this association is critical as
multiply transfused patients are at greater risk of acquiring the
virus. Human metapneumovirus, the most recently discovered
virus, causes a range of upper respiratory tract diseases
varying from severe bronchiolitis to pneumonia in both
children and adults.7
When TTV, a small non-enveloped DNAvirus isolated from
a patient with non A-G post-transfusion hepatitis, was
originally described it was thought to play a role in the
development of fulminant hepatitis and acute and chronic liver
disease of unknown aetiology.11 However, evidence of the high
prevalence of TTV infection in healthy blood donors and the
lack of an evident epidemiological link to disease now suggests
that the role it may play in liver disease in uncertain. The
prevalence in blood donor groups varies from 1.9% to 83%12,13
depending on the geographical area studied and the region of
the viral genome amplified by the polymerase chain reaction
(PCR). The early TTV PCR studies underestimated the true
prevalence of infection in different population groups because
little was known about the genetic variation of the virus.
However, by targeting a more conserved region of the TTV
genome detection has improved, with more sensitive and
reliable results.14,15
Sequence analysis of full-length and partial sequences of
TTV from around the world indicates that the virus can be
classified into six different genotypes (G1 - G6) with a sequence
divergence of > 30%.16 The most commonly recognised
genotypes worldwide are G1, G2 and G3, although the latter
has yet to be found in Africa.
This study was undertaken to determine the true prevalence
of TTV infection in a rural community in South Africa using
three different PCR primer sets and to identify the genotypes
circulating within this population.
Blood samples were obtained from 75 consenting adults
living in the Eastern Cape, as previously described.17 All
participants lived in traditional mud houses with no access to
an indoor water supply or waterborne sewerage.
DNAwas extracted from serum and amplified by PCR with
three independent primer sets targeting different regions of the
TTV genome to assess which would detect virus most
sensitively.13-15 The PCR products amplified from the N22 region
of open reading frame 1 (ORF1) were cloned, sequenced and
aligned with known sequences obtained from the GenBank
database. A phylogenetic tree was constructed to demonstrate
the genetic relatedness, using the neighbour-joining method.
The TTV prevalence varied from 17%  to 84% depending on
the primer set used for genome amplification. The most
sensitive PCR assays were those using primers designed to
amplify the conserved 5’ non-coding region (5’NCR) of the
genome. Of the 75 samples tested, 15 (20%) were positive in all
three systems and 10 (13%) negative.
This study confirms the lack of sensitivity of the PCR system
which targets the N22 region of ORF1 as originally described
by Nishizawa et al.,5 and is certainly due to the high genetic
variability in this region of the genome between different viral
genotypes. Enhanced sensitivity can been achieved by
amplifying the conserved 5’NCR and in this study, depending
on the primer set used, 55% or 84% of rural adults showed
evidence of TTV infection compared with 17% using primers to
the N22 region.
The high prevalence of TTV infection (84%) in this South
African rural community is comparable with figures from other
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healthy rural populations in Africa (Tanzania (74%), Gambia
(83%), Ghana (88%) and Egypt (85%)) and in developed
countries around the world (34 - 90%). 12 This suggests that
routes other than the parenteral route must play a role in TTV
transmission. Evidence for the presence of TTV in faeces18 and
saliva19 indicates that horizontal transmission via the faecal-oral
route and aerosols may be important. In addition, domestic
animals have also been shown to harbour the TT virus14 and
this could be another source for human infections, although at
present there are no data available on TTV infections in
domestic animals from Africa.
Phylogenetic analysis showed that of the 15 sequences
analysed, 14 grouped with G1 and only one with G2 (Fig. 1),
thereby confirming the worldwide distribution of these two
genotypes. This study also confirmed previous reports that
there is no evidence for the presence of genotype 3 in Africa,
but this may be due to the low number of isolates reported
from this continent.
This is a new paradigm, where discovered viruses have no
obvious disease association, and are only found because of the
use of molecular techniques. As a result of these findings, we
need to be cautious in interpreting them and be meticulous in
the epidemiological links that are made.However, these novel
techniques also open the window for many potential microbes
to be discovered which do cause diseases for which no
aetiological agent is evident.
Studies like this need to be undertaken around the world in
both healthy  populations and in patients suffering from a
variety of diseases to establish global prevalence rates and to
ascertain any possible disease association. This can then be
used to assess the relevance in the blood transfusion setting.
The high prevalence of TTV in healthy populations in this and
other studies currently suggests that TTV is non-pathogenic
and probably does not cause disease and is not important to
blood transfusion.
Heidi E M Smuts
Division of Medical Virology/National Health Laboratory Service (NHLS)
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Fig. 1. Phylogenetic tree generated by neighbour-joining analysis of the N22
region of ORF 1. Bootstrap values of greater than 75% are indicated on the
nodes of the tree. The branch lengths are proportional to the evolutionary
distances as shown on the scale. Sequences from this study are represented in
bold type. Representative sequences of the different genotypes (indicated by
accession numbers) including a divergent TTV isolate (PMV), used as the
outgroup, were obtained from GenBank.
